Evogene Ltd. (EVGN)
0.3822
-0.02
(-4.09%)
USD |
NASDAQ |
Oct 09, 16:00
0.3907
+0.01
(+2.22%)
Pre-Market: 20:00
Evogene Enterprise Value : 6.981M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 6.981M |
| October 08, 2026 | 7.202M |
| October 07, 2026 | 7.366M |
| October 06, 2026 | 7.543M |
| October 05, 2026 | 7.274M |
| October 02, 2026 | 7.561M |
| October 01, 2026 | 7.704M |
| September 30, 2026 | 7.183M |
| September 29, 2026 | 7.358M |
| September 28, 2026 | 6.952M |
| September 25, 2026 | 7.435M |
| September 24, 2026 | 7.547M |
| September 23, 2026 | 7.930M |
| September 22, 2026 | 8.488M |
| September 21, 2026 | 8.075M |
| September 18, 2026 | 8.562M |
| September 17, 2026 | 8.621M |
| September 16, 2026 | 8.519M |
| September 15, 2026 | 8.956M |
| September 14, 2026 | 8.506M |
| September 11, 2026 | 8.306M |
| September 10, 2026 | 8.313M |
| September 09, 2026 | 8.603M |
| September 08, 2026 | 8.679M |
| September 04, 2026 | 9.089M |
| Date | Value |
|---|---|
| September 03, 2026 | 9.185M |
| September 02, 2026 | 9.109M |
| September 01, 2026 | 8.857M |
| August 31, 2026 | 9.07M |
| August 28, 2026 | 9.247M |
| August 27, 2026 | 9.090M |
| August 26, 2026 | 9.158M |
| August 25, 2026 | 9.246M |
| August 24, 2026 | 9.374M |
| August 21, 2026 | 9.422M |
| August 20, 2026 | 9.395M |
| August 19, 2026 | 9.942M |
| August 18, 2026 | 9.694M |
| August 17, 2026 | 9.388M |
| August 14, 2026 | 9.940M |
| August 13, 2026 | 10.62M |
| August 12, 2026 | 10.09M |
| August 11, 2026 | 11.29M |
| August 10, 2026 | 10.37M |
| August 07, 2026 | 9.931M |
| August 06, 2026 | 11.08M |
| August 05, 2026 | 10.35M |
| August 04, 2026 | 10.61M |
| August 03, 2026 | 9.063M |
| July 31, 2026 | 8.183M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 79.49M |
| Pluri, Inc. | 43.00M |
| Scinai Immunotherapeutics Ltd. | 7.027M |
| CollPlant Biotechnologies Ltd. | 4.779M |
| Regentis Biomaterials Ltd. | 53.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.591M |
| Revenue (Quarterly) | 0.347M |
| Total Expenses (Quarterly) | 1.939M |
| EPS Diluted (Quarterly) | -0.1449 |
| Gross Profit Margin (Quarterly) | -2.31% |
| Profit Margin (Quarterly) | -458.5% |
| Earnings Yield | -238.7% |
| Normalized Earnings Yield | -238.67 |